Evidence map›Paper›PMID 38143901›Full record

ArticleEvolutionary applications2023

Biological lessons for strategic resistance management.

Daniel T Blumstein, Norman A Johnson, Nurit D Katz, Samuel Kharpatin, Xochitl Ortiz-Ross, Eliseo Parra, Amanda Reshke

Abstract read
In one paragraph

Article in Evolutionary applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel T BlumsteinDepartment of Ecology and Evolutionary Biology University of California Los Angeles Los Angeles California USA.ORCID https://orcid.org/0000-0001-5793-9244
Norman A JohnsonDepartment of Biology University of Massachusetts Amherst Massachusetts USA.
Nurit D KatzDepartment of Ecology and Evolutionary Biology University of California Los Angeles Los Angeles California USA.ORCID https://orcid.org/0000-0002-8974-5601
Samuel KharpatinDepartment of Ecology and Evolutionary Biology University of California Los Angeles Los Angeles California USA.
Xochitl Ortiz-RossDepartment of Ecology and Evolutionary Biology University of California Los Angeles Los Angeles California USA.ORCID https://orcid.org/0000-0002-2598-8268
Eliseo ParraDepartment of Ecology and Evolutionary Biology University of California Los Angeles Los Angeles California USA.ORCID https://orcid.org/0000-0002-0910-3204
Amanda ReshkeDepartment of Ecology and Evolutionary Biology University of California Los Angeles Los Angeles California USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biological resistance to pesticides, vaccines, antibiotics, and chemotherapies creates huge costs to society, including extensive morbidity and mortality. We simultaneously face costly resistance to social changes, such as those required to resolve human-wildlife conflicts and conserve biodiversity and the biosphere. Viewing resistance as a force that impedes change from one state to another, we suggest that an analysis of biological resistance can provide unique and potentially testable insights into understanding resistance to social changes. We review key insights from managing biological resistance and develop a framework that identifies seven strategies to overcome resistance. We apply this framework to consider how it might be used to understand social resistance and generate potentially novel hypotheses that may be useful to both enhance the development of strategies to manage resistance and modulate change in socio-ecological systems.

Indexed as

microbial resistancepesticide resistancesocial changesocial resistancesustainability

Identifiers

PMID38143901
PMCPMC10739074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.